Percutaneous Laparoscopy for Ovarian Tissue Cryopreservation.
1 other identifier
observational
59
1 country
1
Brief Summary
To compare surgical outcomes of oncologic patients that underwent conventional laparoscopy and percutaneous laparoscopy for cryopreservation of ovarian tissue.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started May 2021
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 10, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2021
CompletedFirst Submitted
Initial submission to the registry
August 11, 2021
CompletedFirst Posted
Study publicly available on registry
November 24, 2021
CompletedNovember 24, 2021
November 1, 2021
2 months
August 11, 2021
November 15, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Post-operative pain
Post-operative pain is evaluated with VAS score ranging from 1 to 10 (higher score, maximum pain)
0-1 and 2 days after surgery
Aesthetic outcomes
General satisfaction regarding aesthetic outcomes is collected with a satisfaction survey. The score ranged from 1 to 5, with 1 indicating "very dissatisfied" and 5 "very satisfied".
minimum 3 months after surgery
Secondary Outcomes (4)
Recovery time
Days
Operative time
1 day
Blood loss
1 day
Surgical complications
30 days
Study Arms (2)
Percutaneous laparoscopy
Laparoscopy with percutaneous grasp (2.9 mm).
Conventional laparoscopy
Conventional laparoscopy with conventional laparoscopic trocars (10 or 5 mm).
Interventions
Ovarian tissue explant for cryopreservation of ovarian tissue
Eligibility Criteria
Women with histological diagnosis of malignancy during reproductive age undergoing ovarian tissue explant for ovarian tissue cryopreservation, from Aug 2017 to Jun 2021.
You may qualify if:
- Oncologic women with desire to preserve fertility
You may not qualify if:
- Ovarian explant with different techniques than laparoscopy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
IRCCS "Regina Elena" National Cancer Institute
Rome, Lazio, 00144, Italy
Related Publications (1)
Chiofalo B, Bruno V, Calandra M, Savone D, Mancini E, Baiocco E, Iacobelli M, Giannini A, Vizza E. Percutaneous-assisted laparoscopy for ovarian tissue cryopreservation: a single-center experience. Arch Gynecol Obstet. 2022 Oct;306(4):1329-1335. doi: 10.1007/s00404-022-06684-0. Epub 2022 Jul 10.
PMID: 35819490DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Benito Chiofalo
IRCCS "Regina Elena" National Cancer Institute
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
August 11, 2021
First Posted
November 24, 2021
Study Start
May 10, 2021
Primary Completion
July 1, 2021
Study Completion
August 1, 2021
Last Updated
November 24, 2021
Record last verified: 2021-11